| Vol. 16.31 – 11 August, 2021 |
| |
|
|
| Researchers systematically dissected OCT4 to show that nucleosome binding was encoded within the DNA-binding domain and yet could be uncoupled from free-DNA binding. They found that stable interactions between OCT4 and nucleosomes were continuously required for maintaining the accessibility of pluripotency enhancers in stem cells. [Nature Cell Biology] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists reported a protocol that leveraged PRRX1–tdTomato reporter human PSCs for the selective induction of expandable and ontogenetically defined PRRX1+ limb-bud-like mesenchymal cells under defined xeno-free conditions. [Nature Biomedical Engineering] |
|
|
|
| Investigators generated sensorimotor organoids containing physiologically functional neuromuscular junctions and applied the model to different subgroups of amyotrophic lateral sclerosis. [Nature Communications] |
|
|
|
| The authors showed that the CCCTC-binding factor (CTCF) was a barrier for 2C-like reprogramming. Depletion of CTCF in ESCs efficiently promoted spontaneous and asynchronous conversion to a 2C-like state and was reversible upon restoration of CTCF levels. [Nature Communications] |
|
|
|
| Scientists detailed a six-stage planar differentiation methodology for generating human pluripotent stem cell–derived pancreatic β cells that secreted high amounts of insulin in response to glucose stimulation. [Nature Protocols] |
|
|
|
| Researchers discussed the relevance of detecting mutations for various human PSCs (hPSCs) applications, and presented a detailed protocol to identify cancer-related point mutations using data from RNA sequencing, an assay commonly performed during the growth and differentiation of hPSCs. [Nature Protocols] |
|
|
|
| Investigators developed a novel strategy for the rapid and efficient differentiation of mast cells from human iPSCs. [Journal of Allergy and Clinical Immunology] |
|
|
|
| Scientists generated an iPSC line from bone marrow-mesenchymal stem cells employing a non-integrating episomal vector. The generated iPSCs expressed pluripotency markers, showed a normal karyotype, and exhibited the potential for in vitro differentiation into three germ layers. [Stem Cell Research] |
|
|
|
| The authors reprogrammed skin fibroblasts from a hypertrophic cardiomyopathy patient carrying a heterozygous MYBPC3 truncating mutation into human iPSC (hiPSC) and used CRISPR/Cas9 to generate bi-allelic MYBPC3 truncating mutation and isogenic control hiPSC lines. [Stem Cell Research] |
|
|
|
| Researchers performed a comprehensive analysis of the transcriptional changes occurring during human iPSC (hiPSC) differentiation to cardiomyocytes. Using single cell RNA-seq, they sequenced > 20,000 single cells from 55 independent samples representing two differentiation protocols and multiple hiPSC lines. [Scientific Reports] |
|
|
|
|
| Investigators detail the benefits of using iPSCs in natural killer cell immunotherapies and discuss the challenges that must be overcome before this approach becomes mainstream in the clinic. [Molecules and Cells] |
|
|
|
|
| Yogita Adlakha, an Inspire Faculty Fellow, has developed human-based models to study neuron development and neurodevelopmental disorders such as autism, which can help design treatment strategies for such brain disorders. [Outlook India] |
|
|
|
|
| October 27 – 29, 2021 Virtual |
|
|
|
|
|
| The Scripps Research Institute – La Jolla, California, United States |
|
|
|
| Philipps University of Marburg – Marburg, Germany |
|
|
|
| MSH Medical School Hamburg – Hamburg, Germany |
|
|
|
| Dalhousie University – Halifax, Nova Scotia, Canada |
|
|
|
| UCLA Jules Stein Eye Institute – Los Angeles, California, United States |
|
|
|
|